BioSpace News Archive

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research. [20-September-2019] BOSTON , Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyu

Bayer will present new data from the company’s expanding oncology business at the European Society for Medical Oncology (ESMO) Congress 2019, taking place September 27 to October 1 in Barcelona, Spain.

Newron Pharmaceuticals S.pA. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, is pleased to note its partner Meiji Seika Pharma Co., Ltd., together with Eisai Co., Ltd., have announced the manufacturing and marketing approval in Japan for Equfina® TABLETS

Pioneering Organic Chemist, Professor of Medicinal Chemistry First to Isolate Cannabinoids Leading to the Breakthrough Discoveries of the Endocannabinoid System, Total Synthesis of THC in 1960s

The Physicians Committee for Responsible Medicine, a nonprofit with 12,000 doctor members, has asked American Heart Association President Robert Harrington, MD, to withdraw the AHA’s recently-recommended beverage guidelines for children, due to concerns over dairy industry funding.

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that three posters highlighting clinical data for COPIKTRA™ (duvelisib) will be presented at the 18th Annual International Workshop on Chronic Lymphocytic Leukemia taking place September 20-23, 2019, in Edinburgh, UK.

Stanford Medicine has been ranked in the top ten percent among peer academic medical centers (AMCs) for both inpatient and outpatient care by Vizient, Inc., the nation’s leading health care performance improvement company that measures overall safety and quality in patient care.

The global pharyngeal cancer therapeutics market is expected to post a CAGR of over 6% during the period 2019-2023, according to the latest market research report by Technavio

KCI, an Acelity Company, today announced the availability of PREVENA RESTOR BELLA•FORM™ System, specifically designed to manage post-operative incisions, as well as the surrounding soft tissue envelope following surgical procedures, to stabilize the incision and surrounding surgical area, reduce edema and help improve healing.

Sono-Tek Corporation (OTCQX:SOTK) is pleased to announce that Sono-Tek has entered into an agreement with Avior Bio Incorporated for Sono-Tek ultrasonic coating equipment to be used in the Avior product development and future manufacturing process.